Quality of medical care for persons with serious mental illness: a comprehensive review

EE McGinty, J Baller, ST Azrin, D Juliano-Bult… - Schizophrenia …, 2015 - Elsevier
Objectives Prior studies suggest variation in the quality of medical care for somatic
conditions such as cardiovascular disease and diabetes provided to persons with SMI, but to …

Association of statin use with peripheral neuropathy in the US population 40 years of age or older (美国40 岁及以上人群的他汀使用情况与周围神经病变的关系)

EF Tierney, DJ Thurman, GL Beckles… - Journal of …, 2013 - Wiley Online Library
摘要背景周围神经病变是一种严重的糖尿病并发症, 在某些情况下可导致下肢丧失功能甚至截肢
. 自从他汀类药物问世以来, 其使用日益增加. 最近的报告表明他汀类药物可以影响周围神经病变 …

Secondary prevention of atherosclerotic cardiovascular disease in older adults: a scientific statement from the American Heart Association

JL Fleg, DE Forman, K Berra, V Bittner, JA Blumenthal… - Circulation, 2013 - Am Heart Assoc
Over the decade since the original scientific statement was published, there has been an
explosion of randomized controlled trials (RCTs) addressing secondary prevention of …

Rosuvastatin for primary prevention in older persons with elevated C-reactive protein and low to average low-density lipoprotein cholesterol levels: exploratory …

RJ Glynn, W Koenig, BG Nordestgaard… - Annals of internal …, 2010 - acpjournals.org
Background: Randomized data on statins for primary prevention in older persons are limited,
and the relative hazard of cardiovascular disease associated with an elevated cholesterol …

National trends in heart failure hospitalization after acute myocardial infarction for Medicare beneficiaries: 1998–2010

J Chen, AFC Hsieh, K Dharmarajan, FA Masoudi… - Circulation, 2013 - Am Heart Assoc
Background—Previous studies have reported conflicting findings regarding how the
incidence of heart failure (HF) after acute myocardial infarction (AMI) has changed over time …

Persisting gender differences and attenuating age differences in cardiovascular drug use for prevention and treatment of coronary heart disease, 1998–2010

C Koopman, I Vaartjes, EM Heintjes… - European heart …, 2013 - academic.oup.com
Background Evidence on recent time trends in age–gender differences in cardiovascular
drug use is scarce. We studied time trends in age–gender-specific cardiovascular drug use …

Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis

S Setoguchi, RJ Glynn, J Avorn, MA Mittleman… - Journal of the American …, 2008 - jacc.org
Objectives: We sought to assess the relationship between increasing use of cardiovascular
medications and trends in long-term prognosis after myocardial infarction (MI) in the elderly …

Gender disparities in blood pressure control and cardiovascular care in a national sample of ambulatory care visits

S Keyhani, JV Scobie, PL Hebert, MA McLaughlin - Hypertension, 2008 - Am Heart Assoc
The purpose of this study was to provide an analysis of gender-based disparities in
hypertension and cardiovascular disease care in ambulatory practices across the United …

Population-wide cohort study of statin use for the secondary cardiovascular disease prevention in Scotland in 2009–2017

I Thalmann, D Preiss, I Schlackow, A Gray, B Mihaylova - Heart, 2023 - heart.bmj.com
Objective To estimate the extent of suboptimal statin use for the secondary prevention of
atherosclerotic cardiovascular disease (ASCVD) at different stages of the treatment pathway …

Role of disease risk scores in comparative effectiveness research with emerging therapies

RJ Glynn, JJ Gagne… - … and drug safety, 2012 - Wiley Online Library
Background Usefulness of propensity scores and regression models to balance potential
confounders at treatment initiation may be limited for newly introduced therapies with …